Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Par... oleh Andreas W. Wolff, Helen Bidner, Yvonne Remane, Janine Zimmer, Dag Aarsland, Dag Aarsland, Olivier Rascol, Richard K. Wyse, Alexander Hapfelmeier, Alexander Hapfelmeier, Paul Lingor, Paul Lingor, Paul Lingor